Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
CONDENSED RING GROUP AZACYCLOBUTYL TRIAZOLE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF IN MEDICINE
Document Type and Number:
WIPO Patent Application WO/2018/113694
Kind Code:
A1
Abstract:
The present invention relates to a condensed ring group azacyclobutyl triazole derivative, a preparation method therefor and use thereof in medicine. In particular, the present invention relates to a novel condensed ring group azacyclobutyl triazole derivative as represented by general formula (I), a preparation method therefor, a pharmaceutical composition comprising the derivative, use thereof as a therapeutic agent, in particular as an oxytocin antagonist, and use thereof in the preparation of a medicament used for treating or preventing a disease or a condition that is known or can exhibit a beneficial effect of inhibiting oxytocin. The definition for each substituent in general formula (I) is the same as that in the description.

Inventors:
LI XIN (CN)
HE WEI (CN)
WANG BIN (CN)
ZHANG ZHIGAO (CN)
HE FENG (CN)
TAO WEIKANG (CN)
Application Number:
PCT/CN2017/117421
Publication Date:
June 28, 2018
Filing Date:
December 20, 2017
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
JIANGSU HENGRUI MEDICINE CO (CN)
SHANGHAI HENGRUI PHARMACEUTICAL CO LTD (CN)
International Classes:
C07D401/14; A61K31/397; A61K31/4196; A61P15/00
Domestic Patent References:
WO2005028452A12005-03-31
WO2005082866A22005-09-09
WO2006077496A12006-07-27
WO2006092731A12006-09-08
WO2006100588A12006-09-28
WO2006100557A12006-09-28
WO2009065919A22009-05-28
WO2012094462A22012-07-12
WO2015180612A12015-12-03
Foreign References:
CN101107243A2008-01-16
Other References:
LAN ET AL., REPROD BIOMED ONLINE, vol. 25, no. 3, 2012, pages 254 - 60
AKERLUND ET AL., ANN. NY ACAD. SCI., vol. 734, 1994, pages 47 - 56
GIMPLFAHRENHOLZ, PHYSIOLOGICAL REVIEWS, vol. 81, no. 2, 2001, pages 629 - 683
LIKEWISEMESTON ET AL., ARCH. GEN. PSYCHIATRY, vol. 57, no. 11, 2000, pages 1012 - 30
ISHAK ET AL., J. SEX MED., vol. 5, no. 4, 2007, pages 1022 - 4
MCMAHON, J. UROL., vol. 197, no. 4S, 2017, pages e1344
CLEMENT ET AL., BR. J. PHARMACOL., vol. 169, 2013, pages 1477 - 85
SHINGHAL, J. SEX MED., vol. 10, 2013, pages 2506 - 17
ALAN D. BORTHWICK, J. MED. CHEM., vol. 53, 2010, pages 6525 - 6538
ORGANIC LETTERS, vol. 16, no. 23, 2014, pages 6160 - 6163
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 20, no. 2, 2010, pages 516 - 520
CHEMISTRY - A EUROPEAN JOURNAL, vol. 21, no. 14, 2015, pages 5561 - 5583
ORGANIC PROCESS RESEARCH & DEVELOPMENT, vol. 19, no. 12, 2015, pages 2067 - 2074
JOURNAL OF MEDICINAL CHEMISTRY, vol. 58, no. 3, 2015, pages 1123 - 1139
CHEMISTRY - A EUROPEAN JOURNAL, vol. 19, no. 31, 2013, pages 10353 - 1035
ANGEWANDTE CHEMIE, INTERNATIONAL EDITION, vol. 53, no. 52, 2014, pages 14559 - 14563
JOURNAL OF MEDICINAL CHEMISTRY, vol. 50, no. 20, 2007, pages 4868 - 4881
TETRAHEDRON: ASYMMETRY, vol. 17, no. 17, 2006, pages 2558 - 2564
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, vol. 90, 2015, pages 834 - 844
BIOORGANIC AND MEDICINAL CHEMISTRY LETTERS, vol. 18, no. 5, 2008, pages 1617 - 1622
See also references of EP 3560918A4
Attorney, Agent or Firm:
GE CHENG & CO., LTD. (CN)
Download PDF: